# Hu-Mik-beta1 to Treat T-Cell Large Granular Lymphocytic Leukemia

> **NCT00076180** · PHASE1 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 9 (actual)

## Conditions studied

- T-Cell Large Granular Lymphocytic Leukemia
- Leukemia, T-Cell Large Granular Lymphocytic

## Interventions

- **BIOLOGICAL:** Hu-MiK-Beta-1

## Key facts

- **NCT ID:** NCT00076180
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03-01
- **Primary completion:** 2010-11-12
- **Final completion:** 2019-01-09
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2019-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00076180

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00076180, "Hu-Mik-beta1 to Treat T-Cell Large Granular Lymphocytic Leukemia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00076180. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*